Hantavirus Pulmonary Syndrome

Infectious Disease Clinics of North America

Volumn 24, Issue 1, 2010, Pages 159-173

  Simpson, Steven Q ^a   Spikes, Leslie ^a   Patel, Saurin ^a   Faruqi, Ibrahim ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Acute respiratory failure; Hantavirus; Hemorrhagic fever; Pneumonia; Viral pneumonia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTIC ACID; VIRUS VACCINE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; CONJUNCTIVITIS; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DYSPNEA; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEADACHE; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LACTATE BLOOD LEVEL; LUNG FUNCTION TEST; MENINGISM; MYALGIA; NAUSEA; NONHUMAN; ODYNOPHAGIA; OTALGIA; PETECHIA; PREVALENCE; REVIEW; RHINORRHEA; SINUSITIS; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VOMITING;

HANTAVIRUS PULMONARY SYNDROME; HUMANS; SIN NOMBRE VIRUS;

EID: 76549096581     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.10.011     Document Type: Review

References (60)

1. Duchin J.S., Koster F.T., Peters C.J., et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med 330 14 (1994) 949-955
2. Gonzalez-Scarano F., and Nathanson N. Bunyaviridae. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields virology. 3rd edition (1996), Lippincott-Raven Publishers, Philadelphia 1473-1504
3. Goldsmith C.S., Elliott L.H., Peters C.J., et al. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch Virol 140 12 (1995) 2107-2122
4. Schmaljohn C.S., and Dalrymple J.M. Hantaviruses. In: Webster G.W., and Granoff A. (Eds). Encylopedia of virology vol. 2 (1994), Academic Press, London 538-545
5. Elliott R.M., Schmaljohn C.S., and Collett M.S. Bunyaviridae genome structure and gene expression. Curr Top Microbiol Immunol 169 (1991) 91-141
6. National Center for Infectious Diseases. Special Pathogens Branch. All About Hantaviruses. Available at:. http://cdc.gov/ncidod/diseases/hanta/hps/index.htm Accessed February 25, 2009
7. Gavrilovskaya I.N., Shepley M., Shaw R., et al. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95 12 (1998) 7074-7079
8. Spiropoulou C.F., Goldsmith C.S., Shoemaker T.R., et al. Sin Nombre virus glycoprotein trafficking. Virology 308 1 (2003) 48-63
9. Ravkov E.V., Rollin P.E., Ksiazek T.G., et al. Genetic and serologic analysis of Black Creek Canal virus and its association with human disease and Sigmodon hispidus infection. Virology 210 2 (1995) 482-489
10. Klempa B., Fichet-Calvet E., Lecompte E., et al. Hantavirus in African wood mouse, Guinea. Emerg Infect Dis 12 5 (2006) 838-840
11. Lonner B.N., Douglass R.J., Kuenzi A.J., et al. Seroprevalence against Sin Nombre virus in resident and dispersing deer mice. Vector Borne Zoonotic Dis 8 4 (2008) 433-441
12. Lopez N., Padula P., Rossi C., et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220 1 (1996) 223-226
13. Bayard V., Kitsutani P.T., Barria E.O., et al. Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000. Emerg Infect Dis 10 9 (2004) 1635-1642
14. Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary. MMWR Recomm Rep 43 RR-5 (1994) 1-18
15. Douglass R.J., Semmens W.J., Matlock-Cooley S.J., et al. Deer mouse movements in peridomestic and sylvan settings in relation to Sin Nombre virus antibody prevalence. J Wildl Dis 42 4 (2006) 813-818
16. Calisher C.H., Mills J.N., Sweeney W.P., et al. Do unusual site-specific population dynamics of rodent reservoirs provide clues to the natural history of hantaviruses?. J Wildl Dis 37 2 (2001) 280-288
17. Armstrong L.R., Zaki S.R., Goldoft M.J., et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis 172 4 (1995) 1166
18. Kuenzi A.J., Douglass R.J., White Jr. D., et al. Antibody to sin nombre virus in rodents associated with peridomestic habitats in west central Montana. Am J Trop Med Hyg 64 3-4 (2001) 137-146
19. Ramos M.M., Overturf G.D., Crowley M.R., et al. Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents. Pediatrics 108 2 (2001) E27
20. Enria D., Padula P., Segura E.L., et al. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (B Aires) 56 6 (1996) 709-711
21. Padula P.J., Edelstein A., Miguel S.D., et al. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241 2 (1998) 323-330
22. Martinez V.P., Bellomo C., San Juan J., et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 11 12 (2005) 1848-1853
23. Auwaerter P.G., Oldach D., Mundy L.M., et al. Hantavirus serologies in patients hospitalized with community-acquired pneumonia. J Infect Dis 173 1 (1996) 237-239
24. Vitek C.R., Breiman R.F., Ksiazek T.G., et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 22 5 (1996) 824-826
25. Ferrer J.F., Galligan D., Esteban E., et al. Hantavirus infection in people inhabiting a highly endemic region of the Gran Chaco territory, Paraguay: association with Trypanosoma cruzi infection, epidemiological features and haematological characteristics. Ann Trop Med Parasitol 97 3 (2003) 269-280
26. Pini N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis 17 5 (2004) 427-431
27. Levy H., and Simpson S.Q. Hantavirus pulmonary syndrome. Am J Respir Crit Care Med 49 6 (1994) 1710-1713
28. Hallin G.W., Simpson S.Q., Crowell R.E., et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 24 2 (1996) 252-258
29. Baro M., Vergara J., and Navarrete M. [Hantavirus in Chile: review and cases analysis since 1975]. Rev Med Chil 127 12 (1999) 1513-1523 [in Spanish]
30. Cantoni G., Lazaro M., Resa A., et al. Hantavirus pulmonary syndrome in the Province of Rio Negro, Argentina, 1993-1996. Rev Inst Med Trop Sao Paulo 39 4 (1997) 191-196
31. Koster F., Foucar K., Hjelle B., et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 116 5 (2001) 665-672
32. Zaki S.R., Greer P.W., Coffield L.M., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146 3 (1995) 552-579
33. Nolte K.B., Feddersen R.M., Foucar K., et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 26 1 (1995) 110-120
34. Hjelle B., Goade D., Torrez-Martinez N., et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 23 3 (1996) 495-500
35. Dara S.I., Albright R.C., and Peters S.G. Acute sin nombre hantavirus infection complicated by renal failure requiring hemodialysis. Mayo Clin Proc 80 5 (2005) 703-704
36. Peters C.J., Simpson G.L., and Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50 (1999) 531-545
37. Centers for Disease Control and Prevention (CDC). Hantavirus pulmonary syndrome - Chile, 1997. MMWR Morb Mortal Wkly Rep 46 40 (1997) 949-951
38. Castillo C., Naranjo J., Sepulveda A., et al. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120 2 (2001) 548-554
39. Riquelme R., Riquelme M., Torres A., et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis 9 11 (2003) 1438-1443
40. Crowley M.R., Katz R.W., Kessler R., et al. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 26 2 (1998) 409-414
41. Dietl C.A., Wernly J.A., Pett S.B., et al. Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg 135 3 (2008) 579-584
42. Ketai L.H., Williamson M.R., Telepak R.J., et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 191 3 (1994) 665-668
43. Ketai L.H., Kelsey C.A., Jordan K., et al. Distinguishing hantavirus pulmonary syndrome from acute respiratory distress syndrome by chest radiography: are there different radiographic manifestations of increased alveolar permeability?. J Thorac Imaging 13 3 (1998) 172-177
44. Bustamante E.A., Levy H., and Simpson S.Q. Pleural fluid characteristics in hantavirus pulmonary syndrome. Chest 112 4 (1997) 1133-1136
45. Bone R.C., Fisher Jr. C.J., Clemmer T.P., et al. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 17 5 (1989) 389-393
46. Parker M.M., and Parrillo J.E. Septic shock. Hemodynamics and pathogenesis. JAMA 250 24 (1983) 3324-3327
47. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 328 20 (1993) 1471-1477
48. Parrillo J.E., Burch C., Shelhamer J.H., et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 76 4 (1985) 1539-1553
49. Lazaro M.E., Resa A.J., Barclay C.M., et al. [Hantavirus pulmonary syndrome in southern Argentina]. Medicina (B Aires) 60 3 (2000) 289-301 [in Spanish]
50. Saggioro F.P., Rossi M.A., Duarte M.I., et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 195 10 (2007) 1541-1549
51. Hjelle B., Jenison S., Torrez-Martinez N., et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 35 3 (1997) 600-608
52. Mertz G.J., Miedzinski L., Goade D., et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 39 9 (2004) 1307-1313
53. Ye C., Prescott J., Nofchissey R., et al. Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome. Emerg Infect Dis 10 3 (2004) 478-482
54. Mills J.N., Corneli A., Young J.C., et al. Hantavirus pulmonary syndrome-United States: updated recommendations for risk reduction. Centers for disease control and prevention. MMWR Recomm Rep 51 RR-9 (2002) 1-12
55. Peters C.J., and Khan A.S. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis 34 9 (2002) 1224-1231
56. Padula P.J., Edelstein A., Miguel S.D., et al. [Epidemic outbreak of Hantavirus pulmonary syndrome in Argentina. Molecular evidence of person to person transmission of Andes virus]. Medicina (B Aires) 58 Suppl 1 (1998) 27-36 [in Spanish]
57. Toro J., Vega J.D., Khan A.S., et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 4 4 (1998) 687-694
58. Kruger D.H., Ulrich R., and Lundkvist A.A. Hantavirus infections and their prevention. Microbes Infect 3 13 (2001) 1129-1144
59. McClain D.J., Summers P.L., Harrison S.A., et al. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol 60 1 (2000) 77-85
60. Custer D.M., Thompson E., Schmaljohn C.S., et al. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77 18 (2003) 9894-9905